Communicating Risk Information for Obesity
Primary Purpose
Obesity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Genetic
Lifestyle
Sponsored by

About this trial
This is an interventional prevention trial for Obesity focused on measuring obesity, genetics, risk assessment, health behaviors, randomized controlled trial
Eligibility Criteria
Inclusion Criteria:
Must be age 18 or older, active enrollees in the CPMC trial, and able to read and write in English.
Exclusion Criteria:
Individuals that do not meet the inclusion criteria.
Sites / Locations
- Coriell Institute for Medical Research
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
No Intervention
Experimental
Experimental
Experimental
Arm Label
No risk feedback
Genetic risk feedback
Lifestyle risk feedback
Both genetic or lifestyle risk feedback
Arm Description
No obesity risk information given (control)
Only personal genetic risk information provided
Only personal lifestyle risk information provided
Personal genetic and lifestyle information provided
Outcomes
Primary Outcome Measures
Intentions to Lose Weight - Effect of Study Arm on Outcomes
Intention to lose 10lbs in the next 6 months was measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). Responses were examined by study arm.
Intention to Lose Weight - Impact of Risk Status
Intention to lose 10lbs in the next 6 months measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). This was examined by study arm and level of feedback received (high or elevated risk vs low or non-elevated risk).
Intention to Lose Weight - Combined Risk
Intention to lose 10lbs in the next 6 months on a 5-point likert scale (1-strongly disagree; 5-strongly agree). This was examined by study arm and by combined levels of feedback (e.g. elevated genetic risk and non-elevated lifestyle risk)
Secondary Outcome Measures
Full Information
NCT ID
NCT01355224
First Posted
May 4, 2011
Last Updated
January 24, 2017
Sponsor
Boston University
Collaborators
National Human Genome Research Institute (NHGRI)
1. Study Identification
Unique Protocol Identification Number
NCT01355224
Brief Title
Communicating Risk Information for Obesity
Official Title
Communicating Genetic Information for Obesity
Study Type
Interventional
2. Study Status
Record Verification Date
January 2017
Overall Recruitment Status
Completed
Study Start Date
September 2011 (undefined)
Primary Completion Date
September 2013 (Actual)
Study Completion Date
September 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston University
Collaborators
National Human Genome Research Institute (NHGRI)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.
Detailed Description
The investigators will conduct a randomized controlled feasibility trial to examine the short-term impact of personalized risk feedback for obesity. This study is uniquely situated to provide important data on how individuals interpret various sources of risk information and how they arrive at an overall perception of risk for a condition. Taken altogether, study findings will be used to serve as an overall model for future intervention efforts to effectively communicate obesity risk information with the goal of improving weight management and overall population health.
CPMC-The CPMC is an ongoing evidence-based longitudinal research study designed to determine the utility of using personal genome information in health management and clinical decision-making. They collect saliva samples, perform genetic analysis and provide genetic risk feedback for several disease conditions including coronary artery disease and type 2 diabetes. The present study will build upon the existing genetic testing and web feedback infrastructure at Coriell to conduct behavioral science research to address critical public health questions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
obesity, genetics, risk assessment, health behaviors, randomized controlled trial
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
798 (Actual)
8. Arms, Groups, and Interventions
Arm Title
No risk feedback
Arm Type
No Intervention
Arm Description
No obesity risk information given (control)
Arm Title
Genetic risk feedback
Arm Type
Experimental
Arm Description
Only personal genetic risk information provided
Arm Title
Lifestyle risk feedback
Arm Type
Experimental
Arm Description
Only personal lifestyle risk information provided
Arm Title
Both genetic or lifestyle risk feedback
Arm Type
Experimental
Arm Description
Personal genetic and lifestyle information provided
Intervention Type
Genetic
Intervention Name(s)
Genetic
Other Intervention Name(s)
Genetic risk, Genetic risk feedback, FTO gene risk status
Intervention Description
Relative risk estimates will be presented based on individuals' risk for obesity based on FTO genotype results.
Intervention Type
Behavioral
Intervention Name(s)
Lifestyle
Other Intervention Name(s)
Lifestyle risk, Lifestyle risk feedback
Intervention Description
Relative risk estimates will be presented based on individuals' risk for obesity due to lifestyle factors.
Primary Outcome Measure Information:
Title
Intentions to Lose Weight - Effect of Study Arm on Outcomes
Description
Intention to lose 10lbs in the next 6 months was measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). Responses were examined by study arm.
Time Frame
3 months after viewing obesity risk assessment
Title
Intention to Lose Weight - Impact of Risk Status
Description
Intention to lose 10lbs in the next 6 months measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). This was examined by study arm and level of feedback received (high or elevated risk vs low or non-elevated risk).
Time Frame
3 months after viewing obesity risk assessment
Title
Intention to Lose Weight - Combined Risk
Description
Intention to lose 10lbs in the next 6 months on a 5-point likert scale (1-strongly disagree; 5-strongly agree). This was examined by study arm and by combined levels of feedback (e.g. elevated genetic risk and non-elevated lifestyle risk)
Time Frame
3 months from viewing obesity risk assessment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Must be age 18 or older, active enrollees in the CPMC trial, and able to read and write in English.
Exclusion Criteria:
Individuals that do not meet the inclusion criteria.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Catharine Wang, PhD, MSc
Organizational Affiliation
Boston University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Coriell Institute for Medical Research
City
Camden
State/Province
New Jersey
ZIP/Postal Code
08103
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No plan to share data
Citations:
PubMed Identifier
27891830
Citation
Wang C, Gordon ES, Norkunas T, Wawak L, Liu CT, Winter M, Kasper RS, Christman MF, Green RC, Bowen DJ. A randomized trial Examining The Impact Of Communicating Genetic And Lifestyle Risks For Obesity. Obesity (Silver Spring). 2016 Dec;24(12):2481-2490. doi: 10.1002/oby.21661.
Results Reference
background
PubMed Identifier
24216219
Citation
Wang C, Gordon ES, Stack CB, Liu CT, Norkunas T, Wawak L, Christman MF, Green RC, Bowen DJ. A randomized trial of the clinical utility of genetic testing for obesity: design and implementation considerations. Clin Trials. 2014 Feb;11(1):102-13. doi: 10.1177/1740774513508029. Epub 2013 Nov 11.
Results Reference
derived
Learn more about this trial
Communicating Risk Information for Obesity
We'll reach out to this number within 24 hrs